149 related articles for article (PubMed ID: 25377270)
1. Diagnosis of metachronous multiple lung adenocarcinoma at the cut-end by epidermal growth factor receptor mutation status discordance 4 years after sublobar resection for adenocarcinoma in situ: report of a case.
Isaka T; Yokose T; Ito H; Imamura N; Watanabe M; Imai K; Nishii T; Yamada K; Nakayama H; Masuda M
Surg Today; 2015 Oct; 45(10):1330-4. PubMed ID: 25377270
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor mutations in adenocarcinoma in situ and minimally invasive adenocarcinoma detected using mutation-specific monoclonal antibodies.
Nakamura H; Koizumi H; Kimura H; Marushima H; Saji H; Takagi M
Lung Cancer; 2016 Sep; 99():143-7. PubMed ID: 27565930
[TBL] [Abstract][Full Text] [Related]
3. Discrepancy of epidermal growth factor receptor mutation in lung adenocarcinoma presenting as multiple ground-glass opacities.
Liu M; He WX; Song N; Yang Y; Zhang P; Jiang GN
Eur J Cardiothorac Surg; 2016 Nov; 50(5):909-913. PubMed ID: 27032467
[TBL] [Abstract][Full Text] [Related]
4. Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1614-1622.e1. PubMed ID: 35965138
[TBL] [Abstract][Full Text] [Related]
5. Possible delayed cut-end recurrence after limited resection for ground-glass opacity adenocarcinoma, intraoperatively diagnosed as Noguchi type B, in three patients.
Yoshida J; Ishii G; Yokose T; Aokage K; Hishida T; Nishimura M; Onuki T; Noguchi M; Nagai K
J Thorac Oncol; 2010 Apr; 5(4):546-50. PubMed ID: 20357619
[TBL] [Abstract][Full Text] [Related]
6. CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung.
Ozkan E; West A; Dedelow JA; Chu BF; Zhao W; Yildiz VO; Otterson GA; Shilo K; Ghosh S; King M; White RD; Erdal BS
AJR Am J Roentgenol; 2015 Nov; 205(5):1016-25. PubMed ID: 26496549
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor mutation in lung adenocarcinomas: relationship with CT characteristics and histologic subtypes.
Lee HJ; Kim YT; Kang CH; Zhao B; Tan Y; Schwartz LH; Persigehl T; Jeon YK; Chung DH
Radiology; 2013 Jul; 268(1):254-64. PubMed ID: 23468578
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of synchronous primary lung adenocarcinomas based on epidermal growth factor (EGFR) gene status: A case report.
Takuwa T; Tanaka F; Yoneda K; Torii I; Hashimoto M; Okumura Y; Matsumoto S; Kondo N; Hasegawa S
Lung Cancer; 2010 Jun; 68(3):498-500. PubMed ID: 20307913
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutation status in stage I lung adenocarcinoma with different image patterns.
Hsu KH; Chen KC; Yang TY; Yeh YC; Chou TY; Chen HY; Tsai CR; Chen CY; Hsu CP; Hsia JY; Chuang CY; Tsai YH; Chen KY; Huang MS; Su WC; Chen YM; Hsiung CA; Chang GC; Chen CJ; Yang PC
J Thorac Oncol; 2011 Jun; 6(6):1066-72. PubMed ID: 21512404
[TBL] [Abstract][Full Text] [Related]
10. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
[TBL] [Abstract][Full Text] [Related]
11. Molecular Testing in Multiple Synchronous Lung Adenocarcinomas: Case Report and Literature Review.
Rafael OC; Lazzaro R; Hasanovic A
Int J Surg Pathol; 2016 Feb; 24(1):43-6. PubMed ID: 26350052
[TBL] [Abstract][Full Text] [Related]
12. Small-cell carcinoma in the setting of pulmonary adenocarcinoma: new insights in the era of molecular pathology.
Norkowski E; Ghigna MR; Lacroix L; Le Chevalier T; Fadel É; Dartevelle P; Dorfmuller P; Thomas de Montpréville V
J Thorac Oncol; 2013 Oct; 8(10):1265-71. PubMed ID: 24457237
[TBL] [Abstract][Full Text] [Related]
13. Radiopathologic correlation of collision lung cancer with ground-glass opacity.
Uchida S; Tsuta K; Kusumoto M; Shiraishi K; Kohno T; Watanabe SI
Asian Cardiovasc Thorac Ann; 2019 Jan; 27(1):45-48. PubMed ID: 30417682
[TBL] [Abstract][Full Text] [Related]
14. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941
[TBL] [Abstract][Full Text] [Related]
15. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H
J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438
[TBL] [Abstract][Full Text] [Related]
16. Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.
Ikeda K; Nomori H; Mori T; Sasaki J; Kobayashi T
Ann Thorac Surg; 2008 Apr; 85(4):1430-2. PubMed ID: 18355544
[TBL] [Abstract][Full Text] [Related]
17. EGFR mutation and lobar location of lung adenocarcinoma.
Tseng CH; Chen KC; Hsu KH; Tseng JS; Ho CC; Hsia TC; Su KY; Wu MF; Chiu KL; Liu CM; Wu TC; Chen HJ; Chen HY; Chang CS; Hsu CP; Hsia JY; Chuang CY; Lin CH; Chen JJW; Chen KY; Liao WY; Shih JY; Yu SL; Yu CJ; Yang PC; Yang TY; Chang GC
Carcinogenesis; 2016 Feb; 37(2):157-162. PubMed ID: 26645716
[TBL] [Abstract][Full Text] [Related]
18. Delayed cut-end recurrence after wedge resection for pulmonary ground-glass opacity adenocarcinoma despite negative surgical margin.
Sekihara K; Yoshida J; Oda M; Oki T; Ueda T; Ito T; Miyoshi T; Aokage K; Tane K; Tsuboi M
Gen Thorac Cardiovasc Surg; 2020 Jun; 68(6):644-648. PubMed ID: 31321610
[TBL] [Abstract][Full Text] [Related]
19. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
[TBL] [Abstract][Full Text] [Related]
20. Novel EGFR mutation-specific antibodies for lung adenocarcinoma: highly specific but not sensitive detection of an E746_A750 deletion in exon 19 and an L858R mutation in exon 21 by immunohistochemistry.
Seo AN; Park TI; Jin Y; Sun PL; Kim H; Chang H; Chung JH
Lung Cancer; 2014 Mar; 83(3):316-23. PubMed ID: 24412618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
